New genetic study identifies neurological mechanisms as key drivers of chronic cough
The study included almost 30,000 individuals experiencing chronic cough from multiple population health resources including the UK Biobank, EXCEED Study, the Copenhagen Hospital Biobank, Genes & Health and the eMERGE Network.
As the largest and most diverse genetic study of chronic cough to date, researchers uncovered genes involved in neuronal signalling and sensory pathways, revealing a neurological basis for the condition.
The findings advance understanding of cough reflex hypersensitivity as a nervous system-mediated process and open up opportunities for the development of new targeted treatments.
Additionally, the study revealed shared genetics between chronic cough and chronic pain, suggesting shared neurological mechanisms. This insight offers a promising foundation for future research studies and could help inform effective strategies for managing both conditions.
Dr. Kayesha Coley, from the University of Leicester's Genetic Epidemiology group, who led the study, said, 'Our study represents a major step forward for understanding the biological mechanisms underlying the condition, and we hope it will inform future drug developments.'
Chronic cough can severely impact quality of life, often causing fatigue, breathlessness, disturbed sleep, and emotional distress. For many, it becomes a debilitating condition that disrupts everyday life and social interactions.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The National
2 hours ago
- The National
UK taskforce set up to bring injured children from Gaza
The UK will bring injured children from Gaza to NHS hospitals for treatment, after more than a year of campaigning by doctors. As many as 300 children could be taken from Gaza and treated in NHS hospitals, according to reports, with a government representative confirming on Monday they were 'taking plans forward'. Doctors and Palestinian families in the UK have campaigned for injured children to be taken to the UK since 2023 and were ready to pay for the treatment. Three children have made the journey, with the third, 15-year old Majd Al Shagnobi, arriving last week for privately-funded facial reconstruction surgery at Great Ormond Street Hospital. Existing blueprint The government's plan builds on the work of Project Pure Hope, a UK charity which brought those three children from Gaza. The charity had raised enough money to bring up to 50 Gazan children to the UK for treatment, but faced obstacles under the UK's slow moving visa process. Instead, they began moving children from Gaza to hospitals in Italy and other parts of Europe. It took 17 months for the charity to bring its first two children from Gaza to the UK. Project Pure Hope will become part of the Foreign Commonwealth and Development Office task force. Omar Din, a co-founder of Project Pure Hope, said the charity's experience of triage in Gaza and co-ordinating evacuations with international agencies could help the government speed up cases, medical clearances and safe transfers. 'We've done a of groundwork already and we'll be sharing those details. We're asking them to take it as a blueprint,' he told The National. 'We'd be keen to share what worked well, what didn't work well.' UK hospitals are likely to be sought for treating severe burns, limb salvage surgery, trauma centres and conditions that have gone unmanaged for a long time such as diabetes, Mr Din said. The UK also has world leading centres for neuro-rehabilitation. Doctors and hospitals across the UK have long called for children from Gaza to come for treatment, and many UK-based medical professionals are travelling to the strip to support the work of hospitals there. 'We get several people contacting us every day, across communities in the UK, saying they want to help,' Mr Din said. The full details of the plan will be announced in the coming weeks, but it has been suggested that the children would be treated on the NHS, with one parent or guardian accompanying them, and with security checks made by the Foreign Office. Treatment on the NHS would also allow the patients to access treatment across the health system. 'When it's the NHS you've got the entire force available to you,' Mr Din said. Project Pure Hope's privately-funded evacuations will continue in parallel with the government scheme. Fast-tracking required It comes amid overwhelming public pressure for the government to take strong measures to end the war in Gaza, and address the famine. Prime Minister Keir Starmer said last week that the UK was 'urgently accelerating' efforts to bring injured children to the UK, days after he announced terms for the conditional recognition of a Palestinian state sometime in September. More than 50,000 children are estimated to have been killed or injured in Gaza since October 2023, according to Unicef. There are concerns as to whether the UK can ask quickly enough to take evacuate children from Gaza who have urgent needs. Majd spent a year in Gaza with his injuries before he could be moved to Egypt in February of this year. The Israeli tank shell that shattered his jaw has left him unable to smile, talk or eat properly in that time. It was common for children on evacuation lists to die of their injuries or to be killed in a later attack before they had the chance to travel, Mr Din said. The UK had responded to calls in May to evacuate two children, Hatem, a two-year-old orphan with 35 per cent burns, and Karam, aged one, who suffered from an easily treatable birth defect. But they acted too slowly and Italy offered to take the two children, alongside 15 others, in an emergency evacuation on 11 June, Mr Din said. Scottish First Minister John Swinney welcomed the reported plans, but he said he regretted the action did not come sooner. The SNP leader said he had written to Mr Starmer on July 9 urging such action to be taken. 'If the UK government is prepared to evacuate Palestinians for medical treatment it would be entirely welcome. 'My only regret is the UK government has taken this long to act. 'I urge the UK government to do everything in its power to move swiftly so that lives can be saved. And Scotland will play our part.' Labour MP Stella Creasy, who also wrote a letter to the Prime Minister last month urging the treatment of Palestinian children in the UK, said: 'Nobody can see the plight of these children and not be moved, and therefore they need us to move now to provide life-saving and life-changing treatment – the sooner we treat them the more chance of good outcomes. A UK government representative said: 'We are taking forward plans to evacuate more children from Gaza who require urgent medical care, including bringing them to the UK for specialist treatment where that is the best option for their care. 'We are working at pace to do so as quickly as possible, with further details to be set out in due course.'


Khaleej Times
5 hours ago
- Khaleej Times
Jessie J hospitalised weeks after breast cancer surgery
Singer-songwriter Jessie J said that six weeks after she underwent surgery to treat her "early breast cancer", she said she was back in the hospital, reported E! News. "How I spent the last 24 hours," Jessie wrote on her Instagram Stories alongside a photo of an IV in her arm. "Six weeks post surgery and I was back in the same ward I was after my surgery. Not expected or planned." "I had and still have symptoms that pointed towards a blood clot on the lung," she continued. "IT IS NOT A BLOOD CLOT THANK GOD." She said doctors have identified some infection. "They ran a lot of tests which ended up showing I have an infection still trying to figure out what and a little fluid on my lungs," she said, adding, "Finding it hard to breathe in, but I discharged myself last night I hate being in hospital and will continue the investigation as an outpatient," reported E! News. The 37-year-old's hospitalisation came two months after she shared her initial breast cancer diagnosis on social media. And since then, she has been candid about how difficult the journey has been. "The recovery physically is far from quick or easy, and mentally it's been the most challenging time for me," she wrote in a separate post to her Instagram Stories. "Especially as a mum with a toddler and being unable to be the mother I usually am." "Having to change the plans for my career for this year has been frustrating after working so hard to get to this point and excited to do it all," she continued. "But it's life, I know that. And don't get me wrong, getting the all clear is incredible. But that result didn't speed up or make the recovery from the surgery any easier physically." "I love moving and working and being up and active but I can't be right now, and that's what it is," she added. "I am finding the strength in knowing that all can be adjusted to align with a slower pace and the support of my very small inner circle."


Zawya
12 hours ago
- Zawya
Omani research team uses AI to detect genetic heart disorders
Muscat: A groundbreaking research initiative has made significant progress in identifying the genetic causes of cardiomyopathy in the Sultanate of Oman. The study, titled 'Implementation of Machine Learning Approach to Predict Pathogenicity of Genetic Variants Associated with Cardiomyopathy,' utilises Whole Exome Sequencing (WES) and advanced Artificial Intelligence (AI) methodologies to investigate the underlying genetic contributors to this complex heart condition. The research was led by Dr. Ahmed Al Amri, Consultant of Molecular Genetics Lab and Head of Training and Professional Staff Development at the National Genetics Centre of the Royal Hospital. Cardiomyopathy, a heterogeneous group of myocardial disorders, remains a significant health burden worldwide. In the Sultanate of Oman, the genetic basis of the disease has been insufficiently characterised, hindering effective diagnosis and intervention. This study aimed to bridge that gap by conducting genetic analysis on a cohort of Omani families affected by cardiomyopathy. Dr. Ahmed Al Amri explained that central to the research is the development of a novel AI-based analysis model called 'CardioVar.' This model is designed to enhance the interpretation of WES data through the integration of more than 50,000 genetic variants and mutations linked to cardiomyopathy, supported by multiple AI algorithms to ensure analytical precision. The research project achieved a diagnostic success rate of over 80%, uncovering both known and previously unreported genetic mutations, some of which involve genes not previously linked to cardiomyopathy. These findings offer valuable insight into the genetic landscape of the disease within the Omani population and present new opportunities for further research to confirm the clinical relevance of novel variants. The AI model significantly improved both the speed and accuracy of genetic analysis, demonstrating its practical value in overcoming the limitations of traditional sequencing approaches. Dr. Al Amri emphasised that this approach not only advances the understanding of the genetic basis of cardiomyopathy in the Sultanate of Oman but also provides a scalable framework for implementing AI in genomic medicine, enhancing diagnostic accuracy and personalised care. The multidisciplinary research team included Dr. Ahmed Al Amri, Dr. Aisha Al Balushi, Nibras Al Mahrami, Dr. Musallam Al Ariami, Dr. Nadia Al Hashimi, Dr. Mohammed Al Rawahi, Dr. Tuqa Al Lawati, Dr. Bushra Al Shamsi, Dr. Fahad Al Hattali, and Ms. Mashael Al Balushi. Together, they have contributed to a practical model that blends clinical knowledge, laboratory science, and artificial intelligence to achieve high-impact results. This research not only advances the scientific understanding of inherited cardiomyopathy in the Sultanate of Oman but also exemplifies how AI can transform genetic diagnostics. It stands as a national model for the integration of precision medicine into routine clinical care, with plans to expand the study to include other hereditary heart conditions and incorporate its findings into everyday healthcare practices. © Muscat Media Group Provided by SyndiGate Media Inc. (